Blogopmaak
DCRT presentation at the FEBS session on RNA therapeutics for genetic and infectious disease session
Annemieke Aartsma-Rus presented about the DCRT during the RNA therapeutics for genetic and infectious disease seminar that was organized during the BioSummit by FEBS, IUBMB and PABMB in Lisbon Portugal on July 12th. The session was chaired by Prof Fragkoulis and Prof Viguera and featured an introduction to RNA therapies by Prof Desviat (via zoom due to COVID), an overview of opportunities for DNA and RNA vaccines by Prof Pavlakis and the concept of developing individualized antisense oligonucleotides by Prof Aartsma-Rus. The session was very well attended and was followed by a lively discussion with the audience.
posted on July 21, 2022
Two new DCRT papers have been published online
Team DCRT went for its annual outing to Leiden's escape rooms
N=1 Collaborative is looking for communication trainees
PhD Position in treatment-response fluid biomarkers for ASO treatments
Short report of the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
DCRT travel grants awarded to 3 PhD students
Dr Marlen Lauffer, a senior researcher at the Dutch Center for RNA Therapeutics, was invited to give a talk at the Genomics England research summit in London on the 9th of July. She presented DCRT's work on the identification of genes and diseases and guidelines for patient selection.
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam